| Entry |
|
|---|
| Name |
Alphamethadol (INN) |
|---|
| Formula |
C21H29NO
|
|---|
| Exact mass |
311.2249
|
|---|
| Mol weight |
311.4611
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
Analgesic
DG01984 Opioid analgesics
|
|---|
| Efficacy |
Analgesic (narcotic), Opioid receptor agonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01564 Opioid receptor agonist
DG01563 mu-Opioid receptor agonist
D12674 Alphamethadol
Analgesic
DG01984 Opioid analgesics
D12674 Alphamethadol
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D12674 Alphamethadol (INN)
Narcotics and psychotropics in Japan [br08308.html]
Narcotics by Control Act Article 2 Table 1 (74 substances)
D12674
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 23
1 C8x C 15.4619 -17.3509
2 C8x C 15.4619 -18.6802
3 C8x C 16.6513 -19.3798
4 C8x C 17.8406 -18.6802
5 C8y C 17.8406 -17.3509
6 C8x C 16.6513 -16.6513
7 C8x C 20.2194 -18.6802
8 C8y C 20.2194 -17.3509
9 C1d C 19.0300 -16.6513
10 C8x C 21.3388 -19.3798
11 C8x C 22.5281 -18.6802
12 C8x C 22.5281 -17.3509
13 C8x C 21.3388 -16.6513
14 C1b C 19.0300 -15.2520
15 C1c C 20.2194 -14.6223
16 C1c C 17.0011 -15.5318
17 C1a C 21.3388 -15.2520
18 C1b C 15.8117 -16.2314
19 C1a C 14.6922 -15.5318
20 N1c N 20.2194 -13.2230
21 C1a C 21.3388 -12.5234
22 C1a C 18.9600 -12.5234
23 O1a O 17.0011 -14.1347
BOND 24
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 8 13 2
15 9 14 1
16 14 15 1
17 9 16 1
18 15 17 1
19 16 18 1
20 18 19 1
21 20 21 1
22 20 22 1
23 15 20 1 #Down
24 16 23 1 #Up
|
|---|
